531 related articles for article (PubMed ID: 11280790)
1. Altered expression of Ape1/ref-1 in germ cell tumors and overexpression in NT2 cells confers resistance to bleomycin and radiation.
Robertson KA; Bullock HA; Xu Y; Tritt R; Zimmerman E; Ulbright TM; Foster RS; Einhorn LH; Kelley MR
Cancer Res; 2001 Mar; 61(5):2220-5. PubMed ID: 11280790
[TBL] [Abstract][Full Text] [Related]
2. Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer.
Kelley MR; Cheng L; Foster R; Tritt R; Jiang J; Broshears J; Koch M
Clin Cancer Res; 2001 Apr; 7(4):824-30. PubMed ID: 11309329
[TBL] [Abstract][Full Text] [Related]
3. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor.
Zhang Y; Wang J; Xiang D; Wang D; Xin X
Int J Oncol; 2009 Nov; 35(5):1069-79. PubMed ID: 19787261
[TBL] [Abstract][Full Text] [Related]
4. Expression levels of the DNA repair enzyme HAP1 do not correlate with the radiosensitivities of human or HAP1-transfected rat cell lines.
Herring CJ; Deans B; Elder RH; Rafferty JA; MacKinnon J; Barzilay G; Hickson ID; Hendry JH; Margison GP
Br J Cancer; 1999 Jun; 80(7):940-5. PubMed ID: 10362100
[TBL] [Abstract][Full Text] [Related]
5. Alterations in the expression of the DNA repair/redox enzyme APE/ref-1 in epithelial ovarian cancers.
Moore DH; Michael H; Tritt R; Parsons SH; Kelley MR
Clin Cancer Res; 2000 Feb; 6(2):602-9. PubMed ID: 10690545
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the human apurinic/apyrimidinic endonuclease (APE1) repair activity and sensitization of breast cancer cells to DNA alkylating agents with lucanthone.
Luo M; Kelley MR
Anticancer Res; 2004; 24(4):2127-34. PubMed ID: 15330152
[TBL] [Abstract][Full Text] [Related]
7. The apurinic/apyrimidinic endonuclease (APE/ref-1) DNA repair enzyme is elevated in premalignant and malignant cervical cancer.
Xu Y; Moore DH; Broshears J; Liu L; Wilson TM; Kelley MR
Anticancer Res; 1997; 17(5B):3713-19. PubMed ID: 9427767
[TBL] [Abstract][Full Text] [Related]
8. Studies of apurinic/apyrimidinic endonuclease/ref-1 expression in epithelial ovarian cancer: correlations with tumor progression and platinum resistance.
Freitas S; Moore DH; Michael H; Kelley MR
Clin Cancer Res; 2003 Oct; 9(13):4689-94. PubMed ID: 14581338
[TBL] [Abstract][Full Text] [Related]
9. The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target.
Fishel ML; Kelley MR
Mol Aspects Med; 2007; 28(3-4):375-95. PubMed ID: 17560642
[TBL] [Abstract][Full Text] [Related]
10. APE1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and targeted inhibition of APE1 enhances the activity of cisplatin in A549 cells.
Wang D; Xiang DB; Yang XQ; Chen LS; Li MX; Zhong ZY; Zhang YS
Lung Cancer; 2009 Dec; 66(3):298-304. PubMed ID: 19324449
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of the DNA repair protein APE/REF-1 by CKII affects redox regulation of AP-1.
Fritz G; Kaina B
Oncogene; 1999 Jan; 18(4):1033-40. PubMed ID: 10023679
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of apurinic/apyrimidinic endonuclease expression is associated with the induction of apoptosis in differentiating myeloid leukemia cells.
Robertson KA; Hill DP; Xu Y; Liu L; Van Epps S; Hockenbery DM; Park JR; Wilson TM; Kelley MR
Cell Growth Differ; 1997 Apr; 8(4):443-9. PubMed ID: 9101090
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of Ape1/ref-1 subcellular localization in non-small cell lung carcinomas.
Puglisi F; Aprile G; Minisini AM; Barbone F; Cataldi P; Tell G; Kelley MR; Damante G; Beltrami CA; Di Loreto C
Anticancer Res; 2001; 21(6A):4041-9. PubMed ID: 11911289
[TBL] [Abstract][Full Text] [Related]
14. Major oxidative products of cytosine are substrates for the nucleotide incision repair pathway.
Daviet S; Couvé-Privat S; Gros L; Shinozuka K; Ide H; Saparbaev M; Ishchenko AA
DNA Repair (Amst); 2007 Jan; 6(1):8-18. PubMed ID: 16978929
[TBL] [Abstract][Full Text] [Related]
15. Mapping the protein-DNA interface and the metal-binding site of the major human apurinic/apyrimidinic endonuclease.
Nguyen LH; Barsky D; Erzberger JP; Wilson DM
J Mol Biol; 2000 May; 298(3):447-59. PubMed ID: 10772862
[TBL] [Abstract][Full Text] [Related]
16. Apurinic/apyrimidinic endonuclease expression in pediatric yolk sac tumors.
Thomson BG; Tritt R; Davis M; Perlman EJ; Kelley MR
Anticancer Res; 2000; 20(6B):4153-7. PubMed ID: 11205241
[TBL] [Abstract][Full Text] [Related]
17. Going APE over ref-1.
Evans AR; Limp-Foster M; Kelley MR
Mutat Res; 2000 Oct; 461(2):83-108. PubMed ID: 11018583
[TBL] [Abstract][Full Text] [Related]
18. Apurinic/apyrimidinic endonuclease activity is associated with response to radiation and chemotherapy in medulloblastoma and primitive neuroectodermal tumors.
Bobola MS; Finn LS; Ellenbogen RG; Geyer JR; Berger MS; Braga JM; Meade EH; Gross ME; Silber JR
Clin Cancer Res; 2005 Oct; 11(20):7405-14. PubMed ID: 16243814
[TBL] [Abstract][Full Text] [Related]
19. Tat-APE1/ref-1 protein inhibits TNF-alpha-induced endothelial cell activation.
Song YJ; Lee JY; Joo HK; Kim HS; Lee SK; Lee KH; Cho CH; Park JB; Jeon BH
Biochem Biophys Res Commun; 2008 Mar; 368(1):68-73. PubMed ID: 18206643
[TBL] [Abstract][Full Text] [Related]
20. Nm23-H1 protein binds to APE1 at AP sites and stimulates AP endonuclease activity following ionizing radiation of the human lung cancer A549 cells.
Zhang ZM; Yang XQ; Wang D; Wang G; Yang ZZ; Qing Y; Yang ZX; Li MX; Xiang DB
Cell Biochem Biophys; 2011 Dec; 61(3):561-72. PubMed ID: 21769563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
